CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 34 enrolled
Drug / intervention
Prednisolone +1 moredrug
Likely dose
Prednisolone 2mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01908972
NCT01908972Phase 4Completed
CompareCT.gov

The Safety and Efficiency of Propranolol as an Initial Treatment for Pediatric Hemangioma

Seoul National University Hospital·interventional·Posted Jul 26, 2013·Updated Dec 19, 2018

In Brief

A Phase 4 clinical trial evaluating Prednisolone and Propranolol for Hemangioma. Completed, enrolled 34 participants across 1 site.

Detailed Summary

The purpose of this study is to determine the safety and efficiency of Propranolol as an initial treatment for pediatric hemangioma.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHemangioma
CountriesSouth Korea
Collaborators--

Timeline

Phase 4CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJul 26, 2013
Enrollment StartJun 1, 2013
Primary CompletionMay 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 12.9 years ago

Interventions

Prednisolonedrug

2mg/kg/day for 16weeks

Propranololdrug

2mg/kg/day for 16weeks